Robert J. Heine

Active 1989–2024

135
Papers
38,019
Citations
103
h-index
135
i10-index

Citations

Citations per year for Robert J. Heine1983: 1 citations1989: 1 citations1990: 2 citations1991: 1 citations1992: 4 citations1993: 4 citations1994: 4 citations1995: 3 citations1996: 7 citations1997: 13 citations1998: 27 citations1999: 55 citations2000: 70 citations2001: 129 citations2002: 169 citations2003: 237 citations2004: 273 citations2005: 300 citations2006: 389 citations2007: 492 citations2008: 539 citations2009: 447 citations2010: 459 citations2011: 429 citations2012: 453 citations2013: 415 citations2014: 338 citations2015: 325 citations2016: 261 citations2017: 250 citations2018: 228 citations2019: 698 citations2020: 656 citations2021: 541 citations2022: 451 citations2023: 328 citations2024: 541 citations2025: 268 citations2026: 5 citations1984–1988: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,276 citing papers, 23.9% of this breakdownUnited Kingdom: 1,235 citing papers, 9% of this breakdownChina: 855 citing papers, 6.2% of this breakdownItaly: 747 citing papers, 5.4% of this breakdownNetherlands: 746 citing papers, 5.4% of this breakdownGermany: 621 citing papers, 4.5% of this breakdownCanada: 533 citing papers, 3.9% of this breakdownAustralia: 521 citing papers, 3.8% of this breakdownJapan: 354 citing papers, 2.6% of this breakdownFrance: 336 citing papers, 2.5% of this breakdownSweden: 319 citing papers, 2.3% of this breakdownDenmark: 307 citing papers, 2.2% of this breakdown
0%23.9%Other 28.3%

Fields

  • Medicine82.4%
  • Biochemistry, Genetics and Molecular Biology9.6%
  • Nursing1.8%
  • Neuroscience1.7%
  • Health Professions1%
  • Psychology0.9%
  • Other2.6%

Topics

  • Diabetes Treatment and Management7.4%
  • Diabetes, Cardiovascular Risks, and Lipoproteins7%
  • Diabetes Management and Research5.2%
  • Metabolism, Diabetes, and Cancer3.5%
  • Pancreatic function and diabetes2.6%
  • Diabetes Management and Education2.5%
  • Other71.8%

Coauthors

All papers

Open in search
  1. Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Luis Herandez-Vazquez, Stanley H. Hsia, Michael Jardula, E. Klein, Mark E Kutner, Juan Loy, Francisco G Miranda, Lazaro Nunez, Miguel Mujica-Baella, Alexander V. Murray, Michael Oliver, Ramon Oritz-Carrasquillo, Betsy Palal, Michael T Parke, Athena Philis‐Tsimikas, Raman Purighalla, Julio Rosenstock, Airani Sathananthan, Courtney Shelton, Kanagaratnam Sivalingam, Ehab Sorial, Joseph Soufer, Helen L Stacey, Larry D. Stonesifer, Stanley Stringam, Joanna Van, Jose Vazquez-Tanus, Ramón López de los Reyes, Michelle Welch, Najmuddin Karimjee, Earl E Martin, Ahmed A. Arif, Timothy W Jennings, Neil J. Fraser, Anuj Bhargava, Alan Wynne, Evelyne Davidson, Liana K. Billings, Elizabeth A Barranco-Santana, Michael Dever, Patrick Walsh, A.K. Cho, James W. Chu, Jay H. Shubrook, Albert B. Knouse, Venkatesh Nadar, Lorena Lewy-Alterbaum, Michael Lillestol, Daniel J Humiston, Alexander White, Ronald K. Mayfield, Fahed Bitar, Fernando Cereto, Carmen de la Cuesta, L. de Teresa Parreño, Esteban Jódar Gimeno, Pedro Mezquita‐Raya, Cristobal J Morales Portillo, Miguel Quesada Charneco, Francisco J. Tinahones, Santiago Tofe Povedano, Luis Alberto Vázquez, Carmen Fajardo Montañana, Alfonso González, Cristina Mistodie, Iosif Szilagyi, Adriana Filimon, Nicoleta Mîndrescu, Lavinia Pop, Marlena Pascu and 109 more - The Lancet 2021 cited by 642

  2. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2005 cited by 4,130

  3. Translating the A1C Assay Into Estimated Average Glucose Values

    Authors: , , , , , , - Diabetes Care 2008 cited by 1,815

  4. Impaired Fasting Glucose and Impaired Glucose Tolerance

    Authors: , , , , , , - Diabetes Care 2007 cited by 1,395

  5. Altered Myocardial Substrate Metabolism and Decreased Diastolic Function in Nonischemic Human Diabetic Cardiomyopathy

    Authors: , , , , , , , , , , , , - Journal of the American College of Cardiology 2009 cited by 308

  6. Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study

    Authors: , , , , , , , - The Lancet 2010 cited by 880

  7. Exenatide treatment did not affect bone mineral density despite body weight reduction in patients with type 2 diabetes

    Authors: , , , , , , , , - Diabetes Obesity and Metabolism 2010 cited by 108

  8. Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis

    Authors: , , , , , - Diabetologia 2006 cited by 986

  9. Endothelial Glycocalyx Damage Coincides With Microalbuminuria in Type 1 Diabetes

    Authors: , , , , , , , , , , , , - Diabetes 2006 cited by 434

  10. Pancreatic Fat Content and β-Cell Function in Men With and Without Type 2 Diabetes

    Authors: , , , , , , , , - Diabetes Care 2007 cited by 394

  11. Exenatide Affects Circulating Cardiovascular Risk Biomarkers Independently of Changes in Body Composition

    Authors: , , , , , , , , - Diabetes Care 2010 cited by 156

  12. Safety and efficacy analyses across age and body mass index subgroups in East Asian participants with type 2 diabetes in the phase 3 tirzepatide studies ( SURPASS programme)

    Authors: , , , , , , - Diabetes Obesity and Metabolism 2022 cited by 26

  13. Diabetic encephalopathy: a concept in need of a definition

    Authors: , , , , , , , - Diabetologia 2006 cited by 211

  14. Moderate Alcohol Consumption Lowers the Risk of Type 2 Diabetes

    Authors: , , , , - Diabetes Care 2005 cited by 676

  15. Diabetes, prediabetes and cancer mortality

    Authors: , , , , , , , , , , , , , - Diabetologia 2010 cited by 197

  16. Diabetes‐specific emotional distress mediates the association between depressive symptoms and glycaemic control in Type 1 and Type 2 diabetes

    Authors: , , , , , , , - Diabetic Medicine 2010 cited by 177

  17. Blood Pressure, Lipids, and Obesity Are Associated With Retinopathy

    Authors: , , , , , , , - Diabetes Care 2002 cited by 420

  18. Renal Handling of Urate and Sodium during Acute Physiological Hyperinsulinaemia in Healthy Subjects

    Authors: , , , , , - Clinical Science 1997 cited by 216

  19. Effects of Tirzepatide vs Semaglutide on β-Cell Function, Insulin Sensitivity, and Glucose Control During a Meal Test

    Authors: , , , , , , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2024 cited by 25

  20. Metabolic Syndrome and 10-Year Cardiovascular Disease Risk in the Hoorn Study

    Authors: , , , , , , - Circulation 2005 cited by 631

  21. Trunk Fat and Leg Fat Have Independent and Opposite Associations With Fasting and Postload Glucose Levels

    Authors: , , , , , , , , - Diabetes Care 2004 cited by 418

  22. One-Year Treatment With Exenatide Improves β-Cell Function, Compared With Insulin Glargine, in Metformin-Treated Type 2 Diabetic Patients

    Authors: , , , , , , , , , , , - Diabetes Care 2009 cited by 387

  23. Pioglitazone Improves Cardiac Function and Alters Myocardial Substrate Metabolism Without Affecting Cardiac Triglyceride Accumulation and High-Energy Phosphate Metabolism in Patients With Well-Controlled Type 2 Diabetes Mellitus

    Authors: , , , , , , , , , , , , , - Circulation 2009 cited by 238

  24. Cognitive performance in type 1 diabetes patients is associated with cerebral white matter volume

    Authors: , , , , , , , - Diabetologia 2007 cited by 132